Deutsche Bank’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.4M Sell
299,693
-43,201
-13% -$2.35M 0.01% 895
2025
Q4
$15.8M Sell
342,894
-54,895
-14% -$2.46M 0.01% 945
2025
Q3
$14.3M Buy
397,789
+134,832
+51% +$4.47M ﹤0.01% 938
2025
Q2
$8.55M Sell
262,957
-934,731
-78% -$30.6M ﹤0.01% 1046
2025
Q1
$45.2M Sell
1,197,688
-15,018
-1% -$1.2M 0.02% 643
2024
Q4
$99.3M Buy
1,212,706
+64,522
+6% +$6.41M 0.04% 433
2024
Q3
$131M Buy
1,148,184
+1,018,122
+783% +$91.8M 0.05% 331
2024
Q2
$9.82M Sell
130,062
-6,086
-4% -$414K ﹤0.01% 1013
2024
Q1
$9.3M Sell
136,148
-16,110
-11% -$1.12M ﹤0.01% 1051
2023
Q4
$9.56M Buy
152,258
+77,179
+103% +$4.01M ﹤0.01% 1017
2023
Q3
$3.83M Buy
75,079
+32,099
+75% +$1.58M ﹤0.01% 1113
2023
Q2
$2.15M Sell
42,980
-6,549
-13% -$310K ﹤0.01% 1587
2023
Q1
$1.86M Buy
49,529
+14,034
+40% +$595K ﹤0.01% 1728
2022
Q4
$1.7M Buy
35,495
+11,668
+49% +$458K ﹤0.01% 1746
2022
Q3
$572K Sell
23,827
-2,664
-10% -$67.5K ﹤0.01% 2298
2022
Q2
$576K Buy
26,491
+2,205
+9% +$51K ﹤0.01% 2501
2022
Q1
$587K Sell
24,286
-5,758
-19% -$126K ﹤0.01% 2652
2021
Q4
$714K Buy
30,044
+1,368
+5% +$31.8K ﹤0.01% 2621
2021
Q3
$727K Sell
28,676
-1,029
-3% -$24.9K ﹤0.01% 2808
2021
Q2
$668K Buy
29,705
+10,545
+55% +$216K ﹤0.01% 3038
2021
Q1
$378K Buy
19,160
+5,378
+39% +$135K ﹤0.01% 3272
2020
Q4
$366K Buy
13,782
+4,045
+42% +$150K ﹤0.01% 3120
2020
Q3
$481K Buy
+9,737
New +$388K ﹤0.01% 2659

Other funds holding PCVX